Literature DB >> 9323266

Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour.

J Tiihonen1, J T Kuikka, K A Bergström, J Karhu, H Viinamäki, J Lehtonen, T Hallikainen, J Yang, P Hakola.   

Abstract

Several studies have shown that impulsive violent and suicidal behaviour is associated with a central serotonin deficit, but until now it has not been possible to use laboratory tests with high sensitivity and specificity to study this kind of deficit or to localize the sites of serotonergic abnormalities in the living human brain. The aim of this study was to test the hypothesis that monoamine transporter density in brain is decreased in subjects with impulsive violent behaviour. We studied serotonin (5-HT) and dopamine (DA) transporter specific binding in 52 subjects (21 impulsive violent offenders, 21 age- and sex-matched healthy controls, and ten non-violent alcoholic controls) with single-photon emission tomography (SPET) using iodine-123-labelled 2beta-carbomethoxy-3beta(4-iodophenyl)tropane ([123I]beta-CIT) as the tracer. The blind quantitative analysis revealed that the 5-HT specific binding of [123I]beta-CIT in the midbrain of violent offenders was lower than that in the healthy control subjects (P<0. 005; t test) or the non-violent alcoholics (P<0.05). The results imply that habitual impulsive aggressive behaviour in man is associated with a decrease in the 5-HT transporter density.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323266     DOI: 10.1007/s002590050149

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  13 in total

Review 1.  Psychophysiological correlates of aggression and violence: an integrative review.

Authors:  Christopher J Patrick
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-08-12       Impact factor: 6.237

2.  Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies.

Authors:  Felicia Kamp; Lisa Proebstl; Nora Penzel; Kristina Adorjan; Andrej Ilankovic; Oliver Pogarell; Gabi Koller; Michael Soyka; Peter Falkai; Nikolaos Koutsouleris; Joseph Kambeitz
Journal:  Neuropsychopharmacology       Date:  2018-08-27       Impact factor: 7.853

Review 3.  Endophenotypes as a measure of suicidality.

Authors:  Dimitry A Chistiakov; Zurab I Kekelidze; Vladimir P Chekhonin
Journal:  J Appl Genet       Date:  2012-09-02       Impact factor: 3.240

Review 4.  Genetic polymorphism of serotonin transporter 5-HTTLPR: involvement in smoking behaviour.

Authors:  Maria Angelica Ehara Watanabe; Sandra Odebrecht Vargas Nunes; Sandra Odebrechet Vargas Nunes; Marla Karine Amarante; Roberta Losi Guembarovski; Julie Massayo Maeda Oda; Kalil William Alves De Lima; Maria Helena Pelegrinelli Fungaro
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

Review 5.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

6.  Serotonin transporter promoter polymorphism genotype is associated with temperament, personality traits and illegal drugs use among adolescents.

Authors:  G Gerra; L Garofano; L Castaldini; F Rovetto; A Zaimovic; G Moi; M Bussandri; B Branchi; F Brambilla; G Friso; C Donnini
Journal:  J Neural Transm (Vienna)       Date:  2005-01-24       Impact factor: 3.575

7.  The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT.

Authors:  K Peremans; K Audenaert; Y Hoybergs; A Otte; I Goethals; I Gielen; P Blankaert; M Vervaet; C van Heeringen; R Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06       Impact factor: 9.236

8.  Candidate endophenotypes for genetic studies of suicidal behavior.

Authors:  J John Mann; Victoria A Arango; Shelli Avenevoli; David A Brent; Frances A Champagne; Paula Clayton; Dianne Currier; Donald M Dougherty; Fatemah Haghighi; Susan E Hodge; Joel Kleinman; Thomas Lehner; Francis McMahon; Eve K Mościcki; Maria A Oquendo; Ganshayam N Pandey; Jane Pearson; Barbara Stanley; Joseph Terwilliger; Amy Wenzel
Journal:  Biol Psychiatry       Date:  2009-02-07       Impact factor: 13.382

9.  [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects.

Authors:  Walter Koch; Nadine Schaaff; Gabriele Pöpperl; Christoph Mulert; Georg Juckel; Markus Reicherzer; Christoff Ehmer-von Geiso; Hans-Jürgen Möller; Ulrich Hegerl; Klaus Tatsch; Oliver Pogarell
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

10.  Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms.

Authors:  Kerry J Ressler; Bekh Bradley; Kristina B Mercer; Todd C Deveau; Alicia K Smith; Charles F Gillespie; Charles B Nemeroff; Joseph F Cubells; Elisabeth B Binder
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.